233 Ablation of the stress protease OMA1 protects against heart failure in mice.
http://stm.sciencemag.org/content/10/434/eaan4935
232 Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke.
http://stm.sciencemag.org/content/10/432/eaao1313
231 Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32458-3/fulltext
230 A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)33103-3/fulltext
229 Inhalation of peptide-loaded nanoparticles improves heart failure.
http://stm.sciencemag.org/content/10/424/eaan6205
228 Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
http://www.pnas.org/content/114/45/12033.abstract
227 Heart Repair Using Nanogel-Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction.
http://pubs.acs.org/doi/10.1021/acsnano.7b01008
226 Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis.
https://www.nature.com/articles/s41467-017-01186-z
225 A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32165-7/fulltext
224 Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32249-3/fulltext
|
